Le TGW101 est un diabody liant le TAG-72 conjugué à la toxine de monométhylauristatine E (MMAE). Le TGW101 est administré par voie intraveineuse (IV) en premier et peut se lier au TAG-72 dans ...

The US Food and Drug Administration (FDA) approved the latest versions of COVID-19 vaccines developed by Pfizer and Moderna which target newer variants of the SARS-CoV-2 virus, it was announced ...

The US Food and Drug Administration (FDA) has awarded Neuralink’s brain-computer interface breakthrough device designation for the treatment of individuals with severe speech impairment. The FDA ...

The FDA has laid out its thinking on the design of clinical trials used to support filings for accelerated approval of cancer drugs, with clear signs that it wants to tigh ...

Moderna's combination skin cancer therapy receives FDA's breakthrough tag ...

This week, the FDA granted clearance to Withings’ BPM Pro 2 cellular blood pressure monitor. The device seeks to help providers scale remote patient monitoring for heart failure patients. This ...

Christmas has come a few days early for Spark Therapeutics after the FDA approved its ground-breaking gene therapy for a rare eye disease. The FDA has approved Lilly’s Verzenio, making it the ...

Yesterday, the Federal Trade Commission (FTC) sent a series of seven warning letters to several pharmaceutical companies renewing the agency’s challenge to dozens of patent listings in the U.S ...

The FDA sent a warning letter to Amazon over the sale of mole and skin tag removal products. The agency says there are not any authorized over-the-counter mole removers.

Elon Musk's Neuralink has been granted the FDA's breakthrough device designation for its vision implant, Blindsight. This technology aims to restore sight for those who have lost it or were born ...